Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism
Not Applicable
Recruiting
- Conditions
- Secondary Hypersplenism
- Interventions
- Procedure: microwave ablation of the spleenOther: Splenic artery balloon implantation
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-03-05
- Target Recruit Count
- 35
- Registration Number
- NCT06292715
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer
Recruiting
- Conditions
- Metastatic Biliary Tract Cancer
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-02-28
- Target Recruit Count
- 30
- Registration Number
- NCT06282120
- Locations
- 🇨🇳
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin, China
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
Phase 1
Not yet recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-03-15
- Target Recruit Count
- 96
- Registration Number
- NCT06259058
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
Completed
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- Other: no-Intervention
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-02-05
- Target Recruit Count
- 359
- Registration Number
- NCT06241066
- Locations
- 🇨🇳
Tianjin Cancer Hospital, Tianjin, Tianjin, China
Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
Completed
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- Other: non-intervention
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-02-05
- Target Recruit Count
- 582
- Registration Number
- NCT06241079
Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer
Completed
- Conditions
- the Diffenence of Different Detector Row 4DCT，Especially in Artifects，Radiation Dose and Target Volume
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-01-31
- Target Recruit Count
- 33
- Registration Number
- NCT06233396
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi, Tianjin, Tianjin, China
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-04-01
- Target Recruit Count
- 51
- Registration Number
- NCT06221670
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Recruiting
- Conditions
- Pancreas CancerChemotherapy
- Interventions
- Other: Adjuvant chemotherapy
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 250
- Registration Number
- NCT06208436
- Locations
- 🇨🇳
Jihui, Tianjin, Tianjin, China
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
Phase 2
Recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 268
- Registration Number
- NCT06208826
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.
Completed
- Conditions
- Metastatic Esophageal Squamous Cell Carcinoma
- Interventions
- Drug: Chemotherapy combined with immunotherapyRadiation: radiotherapy
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-02-05
- Target Recruit Count
- 728
- Registration Number
- NCT06190652
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Shanxi Cancer Hospital, Taiyuan, Shanxi, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
© Copyright 2025. All Rights Reserved by MedPath